Genoa, Italy

Alejandra Rodriguez Gimeno

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Fondazione Per La Ricerca Sulla Fibrosi Cistica-on-Lus, Instituto Giannina Gaslini. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alejandra Rodriguez Gimeno. Retrieved from https://idiyas.com/inventor/alejandra-rodriguez-gimeno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alejandra Rodriguez Gimeno: Pioneering Innovation in Sustainable Technology

Introduction:

Alejandra Rodriguez Gimeno is a visionary inventor whose relentless pursuit of innovation and commitment to creating a more sustainable world has positioned her as a trailblazer in the field of technology. With a passion for pushing the boundaries of what is possible, Alejandra's work continues to inspire the next generation of inventors to think boldly and make a positive impact on the world.

Latest Patents:

Alejandra Rodriguez Gimeno has made significant contributions to the field of medicine with her latest patents focusing on the treatment of cystic fibrosis. Her inventions include compounds and compositions for the treatment of cystic fibrosis, as well as heterocyclic derivatives for the same purpose. These patents highlight Alejandra's dedication to developing innovative solutions for improving healthcare and saving lives.

Career Highlights:

Throughout her career, Alejandra Rodriguez Gimeno has collaborated with esteemed institutions such as Fondazione Istituto Italiano Di Tecnologia and Instituto Giannina Gaslini. Her groundbreaking research and inventions have garnered international recognition for their potential to revolutionize the healthcare industry and enhance the quality of life for patients worldwide.

Collaborations:

Alejandra has had the privilege of working alongside brilliant minds in her field, including Tiziano Bandiera and Fabio Bertozzi. These collaborations have not only fueled her passion for innovation but have also enriched the quality of her work, leading to groundbreaking advancements in the treatment of cystic fibrosis.

Conclusion:

Alejandra Rodriguez Gimeno's dedication to innovation, coupled with her commitment to sustainability and healthcare, establishes her as a true pioneer in the field of technology. Her invaluable contributions continue to inspire and motivate inventors worldwide to think outside the box and strive towards a more sustainable, healthier future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…